AMIX (Autonomix Medical) Days Payable : 0.00 (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Autonomix Medical Days Payable?

Autonomix Medical's average Accounts Payable for the three months ended in Dec. 2024 was $0.40 Mil. Autonomix Medical's Cost of Goods Sold for the three months ended in Dec. 2024 was $0.00 Mil.

The historical rank and industry rank for Autonomix Medical's Days Payable or its related term are showing as below:

AMIX's Days Payable is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 69.235
* Ranked among companies with meaningful Days Payable only.

Autonomix Medical's Days Payable stayed the same from Dec. 2023 (0.00) to Dec. 2024 (0.00). stayed the same

Autonomix Medical Days Payable Historical Data

The historical data trend for Autonomix Medical's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Autonomix Medical Days Payable Chart

Autonomix Medical Annual Data

Trend

Mar23

Mar24

Days Payable

Autonomix Medical Quarterly Data
	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Days Payable	Get a 7-Day Free Trial				-	-	-	-	-

Competitive Comparison of Autonomix Medical's Days Payable

For the Medical Devices subindustry, Autonomix Medical's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Autonomix Medical's Days Payable Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Autonomix Medical's Days Payable distribution charts can be found below:

* The bar in red indicates where Autonomix Medical's Days Payable falls into.

Save Embed

;

Save Embed

;

Autonomix Medical Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Autonomix Medical's Days Payable for the fiscal year that ended in Mar. 2024 is calculated as

	Days Payable (A: Mar. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Mar. 2023 )	+	Accounts Payable (A: Mar. 2024 ))	/	count )	/	Cost of Goods Sold (A: Mar. 2024 )	*	Days in Period
=	( (0.173	+	0.492)	/	2 )	/	0	*	365
=	0.3325					/	0	*	365
=	N/A

Autonomix Medical's Days Payable for the quarter that ended in Dec. 2024 is calculated as:

	Days Payable (Q: Dec. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Sep. 2024 )	+	Accounts Payable (Q: Dec. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2024 )	*	Days in Period
=	( (0.574	+	0.232)	/	2 )	/	0	*	365 / 4
=	0.403					/	0	*	365 / 4
=	N/A

Autonomix Medical Days Payable Related Terms

Thank you for viewing the detailed overview of Autonomix Medical's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Autonomix Medical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Autonomix Medical Inc (NAS:AMIX) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

21 Waterway Avenue, Suite 300, Woodlands, TX, USA, 77380

Website

https://www.autonomix.com

Autonomix Medical Inc is a development-stage medical device development company focused on advancing innovative technologies for sensing and treating disorders relating to the nervous system. Its first-in-class technology platform includes a catheter-based microchip-enabled array that can detect and differentiate neural signals with a high degree of sensitivity as demonstrated in animal studies.